Ohio · 136th Legislature (2025-2026) · Bill
SB 227: Cap cost sharing for prescription insulin drugs
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 227 is a bill introduced in the Ohio Senate on July 1, 2025. According to its official title, it concerns: Cap cost sharing for prescription insulin drugs. Primary sponsor: Hearcel Craig (Democratic). It lists 5 additional sponsors. Most recent recorded action (October 1, 2025): Referred to committee.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
To enact section 3902.65 of the Revised Code to cap cost sharing for prescription insulin drugs.
Sponsors
Sponsors by party (alphabetical): Democratic 5
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Hearcel Craig | Primary sponsor | Democratic | Senate | 15 |
| Nickie Antonio | Co-sponsor | Democratic | Senate | 23 |
| Paula Hicks-Hudson | Co-sponsor | Democratic | Senate | 11 |
| Catherine Ingram | Co-sponsor | Democratic | Senate | 9 |
| Nathan H. Manning | Co-sponsor | Not applicable (committee) | — | — |
| Casey Weinstein | Co-sponsor | Democratic | Senate | 28 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Referred to committee
- Introduced